SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-048161
Filing Date
2018-08-23
Accepted
2018-08-23 16:14:13
Documents
2
Period of Report
2018-08-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3885
2 POA DOCUMENT poa.txt EX-24.3_806807 4329
  Complete submission text file 0001209191-18-048161.txt   9783
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Issuer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203
Business Address
Sze Randoll (Reporting) CIK: 0001751011 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38112 | Film No.: 181034902